Gupta S, Zhou E, Ferreira J, Finn A
Brown J Hosp Med. 2025; 1(1):33679.
PMID: 40046444
PMC: 11878847.
DOI: 10.56305/001c.33679.
Zhan J, Chen J, Yu J, Xu F, Xing F, Wang D
World J Gastroenterol. 2025; 31(2):100234.
PMID: 39811510
PMC: 11684194.
DOI: 10.3748/wjg.v31.i2.100234.
Gao W, Huang Y, Wang Y
BMC Gastroenterol. 2024; 24(1):471.
PMID: 39716072
PMC: 11667830.
DOI: 10.1186/s12876-024-03569-1.
Mao Y, Fang Z, He Y, Jin J, Ding X, Kong D
Front Med (Lausanne). 2024; 11:1443581.
PMID: 39606628
PMC: 11598435.
DOI: 10.3389/fmed.2024.1443581.
Tao K, Shan X, He B, Zeng Q, Wu M, Jie L
Therap Adv Gastroenterol. 2024; 17:17562848241299743.
PMID: 39553446
PMC: 11565611.
DOI: 10.1177/17562848241299743.
Percutaneous recanalization of non-cirrhotic extrahepatic portal vein obstruction in children: technical considerations in a preliminary cohort.
Marra P, Franchi-Abella S, Hernandez J, Ronot M, Muglia R, DAntiga L
Eur Radiol. 2024; .
PMID: 39242398
DOI: 10.1007/s00330-024-11040-8.
Transjugular Intrahepatic Portosystemic Shunt in Nonmalignant Noncirrhotic Portal Vein Thrombosis and Portosinusoidal Vascular Disorder.
Shalaby S, Miraglia R, Senzolo M
J Clin Med. 2024; 13(5).
PMID: 38592220
PMC: 10931999.
DOI: 10.3390/jcm13051412.
Correlation of Hepatic Venous Pressure Gradient Level With Clinical and Endoscopic Parameters in Decompensated Chronic Liver Disease.
Sathawane A, Khobragade H, Pal S
Cureus. 2024; 15(12):e51154.
PMID: 38283456
PMC: 10811441.
DOI: 10.7759/cureus.51154.
From Non-Alcoholic Steatohepatitis (NASH) to Hepatocellular Carcinoma (HCC): Epidemiology, Incidence, Predictions, Risk Factors, and Prevention.
Motta B, Masarone M, Torre P, Persico M
Cancers (Basel). 2023; 15(22).
PMID: 38001718
PMC: 10670704.
DOI: 10.3390/cancers15225458.
Efficacy of Vonoprazan vs. Pantoprazole or Non-acid Suppression in Prevention of Post-variceal Ligation Ulcer Bleeding in Portal Hypertension: A Multi-arm Randomized Controlled Trial.
Lashen S, Shamseya M, Shamseya A, Hablass F
J Clin Exp Hepatol. 2023; 13(6):962-971.
PMID: 37975046
PMC: 10643493.
DOI: 10.1016/j.jceh.2023.05.008.
Low liver fat in non-alcoholic steatohepatitis-related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortality.
Lee S, Huang D, Bettencourt R, Ajmera V, Tincopa M, Noureddin N
Aliment Pharmacol Ther. 2023; 59(1):80-88.
PMID: 37968251
PMC: 10807727.
DOI: 10.1111/apt.17783.
Prediction of Esophageal Varices in Viral Hepatitis C Cirrhosis: Performance of Combined Ultrasonography and Clinical Predictors.
Charoenchue P, Na Chiangmai W, Amantakul A, Wanchaitanawong W, Chitapanarux T, Pojchamarnwiputh S
Int J Biomed Imaging. 2023; 2023:7938732.
PMID: 37746529
PMC: 10516699.
DOI: 10.1155/2023/7938732.
Management of Stroke in Patients With Chronic Liver Disease: A Practical Review.
Parikh N, Basu E, Hwang M, Rosenblatt R, VanWagner L, Lim H
Stroke. 2023; 54(9):2461-2471.
PMID: 37417238
PMC: 10527812.
DOI: 10.1161/STROKEAHA.123.043011.
Cirrhotic patients on proton pump inhibitors are at a twofold risk of spontaneous bacterial peritonitis independently of gastrointestinal bleeding: a population-based retrospective study.
Boustany A, Rahhal R, Onwuzo S, Almomani A, Boustany T, Kumar P
Ann Gastroenterol. 2023; 36(3):327-332.
PMID: 37144010
PMC: 10152803.
DOI: 10.20524/aog.2023.0794.
Analysis of Complications and Risk Factors Other than Bleeding before and after Endoscopic Treatment of Esophagogastric Variceal Bleeding in Patients with Liver Cirrhosis.
Duan X, He X, Yan H, Li H, Wang J, Guo S
Can J Gastroenterol Hepatol. 2023; 2023:7556408.
PMID: 37034104
PMC: 10076114.
DOI: 10.1155/2023/7556408.
Evaluation of Low-Molecular-Weight Heparin for Treatment of Portal Vein Thrombosis in Liver Cirrhosis Patients.
Han J, Koh Y, Kim S, Suh S, Cho Y, Lee J
Medicina (Kaunas). 2023; 59(2).
PMID: 36837493
PMC: 9965161.
DOI: 10.3390/medicina59020292.
Evaluation of Liver Stiffness Measurement by Means of 2D-SWE for the Diagnosis of Esophageal Varices.
Hristov B, Andonov V, Doykov D, Doykova K, Valova S, Nacheva-Georgieva E
Diagnostics (Basel). 2023; 13(3).
PMID: 36766459
PMC: 9914861.
DOI: 10.3390/diagnostics13030356.
Selective somatostatin receptor 5 inhibition improves hepatic insulin sensitivity.
Tamura Y, Sugama J, Abe S, Shimizu Y, Hirose H, Watanabe M
Pharmacol Res Perspect. 2022; 11(1):e01043.
PMID: 36585794
PMC: 9803904.
DOI: 10.1002/prp2.1043.
A creatinine-based model for predicting recurrent bleeding after modified percutaneous transhepatic variceal embolization in patients with cirrhosis.
Ji K, Li X, Zhu H, Zhao S, Zhan P, Shi Y
J Interv Med. 2022; 5(2):95-102.
PMID: 35936666
PMC: 9348999.
DOI: 10.1016/j.jimed.2022.03.007.
Non-Invasive Prediction Models for Esophageal Varices and Red Signs in Patients With Hepatitis B Virus-Related Liver Cirrhosis.
Liang H, Si H, Liu M, Yuan L, Ma R, Zhang G
Front Mol Biosci. 2022; 9:930762.
PMID: 35911970
PMC: 9332338.
DOI: 10.3389/fmolb.2022.930762.
